Advertisement

The FDA completes a 3-week inspection of Hospira's Rocky Mount, N.C., facility, which has been under the watchdog agency's eye since an April 2010 warning letter.

Hospira logo

Medical device company Hospira (NYSE:HSP) disclosed an FDA inspection of its Rocky Mount, N.C., facility, saying 5 agency inspectors reviewed the facility for 3 weeks and issued a Form 483 warning flagging 20 problems at the plant.

Hospira will now respond to the 20 observations with a remediation and modernization plan, according to a press release.

Advertisement
Advertisement